Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05666466
Other study ID # Soh-Med-22-12-16
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2022
Est. completion date December 30, 2024

Study information

Verified date December 2022
Source Sohag University
Contact Rania Khalil, MSc
Phone 00201024493093
Email rania.khalil@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

cross-sectional study of population who have ANSD


Description:

Cross-sectional nonivasive study including study and control group aiming to determine site of lesion of auditory neuropathy spectrum disorder either presynaptic or postsynaptic by using electrophysiological measures


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date December 30, 2024
Est. primary completion date July 1, 2023
Accepts healthy volunteers No
Gender All
Age group 12 Years to 50 Years
Eligibility Inclusion Criteria: - Age between 12 and 50 years OAE and CM could be present disproportionate SRS to PTA level Exclusion Criteria: proportionate ABR to PTA level Proportionate SRS to PTA level - presnce ol lesions in CT or MRI

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
extratympanic electrocochleograhy
electrophysiological test

Locations

Country Name City State
Egypt Sohag Faculty of Medicine Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary determination of site of lesion of ANSD differentiation between presynaptic and postsynaptic types of ANSD one and half year
See also
  Status Clinical Trial Phase
Completed NCT01023932 - Auditory Neuropathy and Cochlear Implants N/A
Completed NCT06125015 - Unexpected ABR Results in Patients Suspected With Auditory Neuropathy Spectrum Disorder N/A